Skip to main content
. 2023 Jun 9;10:1169970. doi: 10.3389/fmed.2023.1169970

Table 5.

Treatment response to two cycles of PRRT, according to RECIST 1.1 and MTV-based.

RECIST 1.1 CR PR SD PD
Patients n, (%) 0 (0) 11 (18) 44 (72) 6 (10)
MTV-based
Patients n, (%) 16 (26) 38 (62) 7 (12)